Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-76,805
Closed -$78K 12232
2025
Q4
$78K Sell
76,805
-137,448
-64% -$191K ﹤0.01% 10314
2025
Q3
$355K Buy
+214,253
New +$333K ﹤0.01% 8574
2025
Q2
Sell
-15,933
Closed -$22.4K 10213
2025
Q1
$22.4K Sell
15,933
-11,968
-43% -$19.3K ﹤0.01% 9139
2024
Q4
$45.6K Buy
27,901
+2,046
+8% +$3.22K ﹤0.01% 8994
2024
Q3
$48.9K Buy
+25,855
New +$54.3K ﹤0.01% 9183
2022
Q2
Sell
-14,520
Closed -$103K 10193
2022
Q1
$103K Sell
14,520
-13,614
-48% -$90K ﹤0.01% 9442
2021
Q4
$188K Sell
28,134
-20,959
-43% -$150K ﹤0.01% 8858
2021
Q3
$337K Buy
+49,093
New +$352K ﹤0.01% 7962

Other funds holding INCR

Jane Street's INCR Position: Q1 2026 in Review

Jane Street sold out of Intercure (INCR) in Q1 2026, closing a stake of 76,805 shares — an estimated $78K sold.

Jane Street first reported a position in INCR in Q3 2021 and held it in 8 quarters. The position peaked at $355K in Q3 2025. 15 funds tracked by Wall St. Rank hold INCR as of Q1 2026.

  • Jane Street reported no remaining Intercure position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 76,805 Intercure shares in Q1 2026, an estimated $78K.
  • Jane Street first reported a position in Intercure in Q3 2021 and held it in 8 quarters.
  • Jane Street's Intercure position peaked at $355K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Intercure as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.